A novel mouse prostate carcinogenesis model for dietary cancer prevention researc
用于饮食癌症预防研究的新型小鼠前列腺癌模型
基本信息
- 批准号:8450080
- 负责人:
- 金额:$ 7.29万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-04-01 至 2014-03-31
- 项目状态:已结题
- 来源:
- 关键词:2-Amino-1-Methyl-6-Phenylimidazo[4,5-b]pyridineAnimal ModelAnti-Inflammatory AgentsAnti-inflammatoryAntioxidantsApoptosisAtrophicBCL2 geneCancer EtiologyCarcinogensCarcinomaCell ProliferationCessation of lifeChemopreventive AgentCleaved cellColonCytochrome P450DNA AdductionDevelopmentDietDietary FactorsDrug Metabolic DetoxicationE-CadherinEpidemiologic StudiesEpigallocatechin GallateEpithelial CellsEpitheliumEtiologyFatty acid glycerol estersFishesGSTP1 geneHeterocyclic AminesHumanImmunohistochemistryIn Situ Nick-End LabelingIncidenceInflammationInflammatoryInheritedIntakeLesionLymphoid TissueMalignant NeoplasmsMalignant neoplasm of prostateMammary glandMeatMedicalModelingMolecularMonitorMusNF-kappa BOncogenicOxidative StressPTGS2 genePTPRC genePathogenesisPathway interactionsPhytoestrogensPreventiveProcessProstateProstate carcinomaProstatic Intraepithelial NeoplasiasPublic HealthRattusReportingResearchRiskRisk FactorsSeleniumSignal PathwaySignal TransductionStudy modelsTestingTocopherolsUnited StatesVitamin DWild Type Mouseanticancer researchcancer preventioncancer riskcarcinogenesiscaspase-3cell injurycookingdietary supplementsenvironmental mutagensfoodbornefruits and vegetablesinsightmalemennitrosative stressnovelpreventprostate cancer modelprostate cancer preventionprostate carcinogenesistumor
项目摘要
DESCRIPTION (provided by applicant): The objectives of this project are to develop a novel prostate cancer model using hCYP1A mice and PhIP, to characterize the molecular changes of carcinogenesis, and to determine the prostate cancer preventive activity of a -tocopherol (-T) rich mixture of tocopherols (-TmT) which, unlike -T, is a more effective chemopreventive agent. The hypotheses are: 1) PhIP induces prostate carcinogenesis by causing mutagenic DNA-adduct formation accompanied by oxidative stress and inflammation, 2) a high-fat diet (HFD) can promote carcinogenesis, shortening the experimental period; and 3) -TmT can inhibit prostate carcinogenesis due to its antioxidant and anti-inflammatory actions as well as its inhibition of oncogenic signaling pathways. The specific aims are as follows: Aim 1. Develop the PhIP-induced prostate cancer model in hCYP1A mice and characterize the cellular/molecular changes involved. PhIP will be administered (200mg/kg, po) to male hCYP1A mice maintained on the AIN76A diet; then they will be kept either on AIN76A diet or the HFD (containing 20% fat). The development of prostate lesions and cancer will be monitored at 20, 30, 40, and 50 weeks. We will analyze the development of PIN and carcinoma in the prostate as well as determine the levels of cell proliferation (Ki67 and PCNA), apoptosis (cleaved caspase-3 and TUNEL), inflammation (NF-kB and CD45), and oxidative stress (8-OHdG and -H2AX), as well as the expression of GSTP1, E-cadherin, COX-2, p63, p27, Pten, Nkx3.1, p16, and Bcl-2 by immunohistochemistry (IHC). In the development of a faster model, we can also test the hypothesis that HFD promotes prostate carcinogenesis. The induction of prostate cancer by PhIP added to the diet will also be explored. Aim 2. Determine the prostate cancer preventive activity of tocopherols. The PhIP-treated hCYP1A mice will be put on the HFD or HFD supplemented with -TmT. -TmT is expected to decrease oxidative and nitrosative stress and inflammation as well as oncogenic signaling in the prostate, and prevents or delays the onset of PIN lesions and prostate carcinoma. Impact: This research will make an impact in prostate cancer research by 1) developing a novel and relevant model to study dietary factors and prostate cancer; 2) evaluating high fat diet as a risk factor; and 3) determining -TmT as a chemopreventive agent for prostate cancer.
描述(由申请人提供):该项目的目标是使用 hCYP1A 小鼠和 PhIP 开发一种新型前列腺癌模型,以表征癌发生的分子变化,并确定α-生育酚(-T)的前列腺癌预防活性丰富的生育酚混合物 (-TmT),与 -T 不同,它是一种更有效的化学预防剂。假设是:1)PhIP通过引起诱变DNA加合物形成并伴有氧化应激和炎症来诱导前列腺癌发生;2)高脂饮食(HFD)可以促进癌变,缩短实验周期; 3) -TmT 由于其抗氧化和抗炎作用以及对致癌信号通路的抑制作用,可以抑制前列腺癌的发生。具体目标如下: 目的 1. 在 hCYP1A 小鼠中开发 PhIP 诱导的前列腺癌模型并表征所涉及的细胞/分子变化。将 PhIP(200mg/kg,口服)给予维持 AIN76A 饮食的雄性 hCYP1A 小鼠;然后他们将继续采用 AIN76A 饮食或 HFD(含 20% 脂肪)。将在第 20、30、40 和 50 周时监测前列腺病变和癌症的发展。我们将分析 PIN 和前列腺癌的发展,并确定细胞增殖(Ki67 和 PCNA)、细胞凋亡(裂解的 caspase-3 和 TUNEL)、炎症(NF-kB 和 CD45)和氧化应激的水平。 8-OHdG 和 -H2AX),以及 GSTP1、E-钙粘蛋白、COX-2、p63、p27、Pten、Nkx3.1、通过免疫组织化学 (IHC) 检测 p16 和 Bcl-2。在开发更快的模型时,我们还可以检验 HFD 促进前列腺癌的假设。还将探讨通过添加到饮食中的 PhIP 诱导前列腺癌。目标 2. 确定生育酚的前列腺癌预防活性。 PhIP处理的hCYP1A小鼠将被置于HFD或补充有-TmT的HFD上。 -TmT 有望减少氧化和亚硝化应激以及炎症以及前列腺中的致癌信号传导,并预防或延迟 PIN 病变和前列腺癌的发生。影响:这项研究将对前列腺癌研究产生影响:1)开发一种新颖且相关的模型来研究饮食因素和前列腺癌; 2)评估高脂肪饮食作为危险因素; 3)确定-TmT作为前列腺癌的化学预防剂。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CHUNG S. YANG其他文献
CHUNG S. YANG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CHUNG S. YANG', 18)}}的其他基金
Prevention of Colon Cancer by Epigallocatechin Gallate and Atorvastatin
表没食子儿茶素没食子酸酯和阿托伐他汀预防结肠癌
- 批准号:
7845194 - 财政年份:2009
- 资助金额:
$ 7.29万 - 项目类别:
Prevention of Colon Cancer by Epigallocatechin Gallate and Atorvastatin
表没食子儿茶素没食子酸酯和阿托伐他汀预防结肠癌
- 批准号:
8107848 - 财政年份:2008
- 资助金额:
$ 7.29万 - 项目类别:
Prevention of Colon Cancer by Epigallocatechin Gallate and Atorvastatin
表没食子儿茶素没食子酸酯和阿托伐他汀预防结肠癌
- 批准号:
7661674 - 财政年份:2008
- 资助金额:
$ 7.29万 - 项目类别:
Inhibition of Lung Carcinogenesis by Tea Polyphenols and Atorvastatin
茶多酚和阿托伐他汀抑制肺癌发生
- 批准号:
7586853 - 财政年份:2008
- 资助金额:
$ 7.29万 - 项目类别:
Inhibition of Lung Carcinogenesis by Tea Polyphenols and Atorvastatin
茶多酚和阿托伐他汀抑制肺癌发生
- 批准号:
8212578 - 财政年份:2008
- 资助金额:
$ 7.29万 - 项目类别:
Prevention of Colon Cancer by Epigallocatechin Gallate and Atorvastatin
表没食子儿茶素没食子酸酯和阿托伐他汀预防结肠癌
- 批准号:
7919687 - 财政年份:2008
- 资助金额:
$ 7.29万 - 项目类别:
Prevention of Colon Cancer by Epigallocatechin Gallate and Atorvastatin
表没食子儿茶素没食子酸酯和阿托伐他汀预防结肠癌
- 批准号:
7905863 - 财政年份:2008
- 资助金额:
$ 7.29万 - 项目类别:
Inhibition of Lung Carcinogenesis by Tea Polyphenols and Atorvastatin
茶多酚和阿托伐他汀抑制肺癌发生
- 批准号:
7850510 - 财政年份:2008
- 资助金额:
$ 7.29万 - 项目类别:
Inhibition of Lung Carcinogenesis by Tea Polyphenols and Atorvastatin
茶多酚和阿托伐他汀抑制肺癌发生
- 批准号:
8018089 - 财政年份:2008
- 资助金额:
$ 7.29万 - 项目类别:
Inhibition of Lung Carcinogenesis by Tea Polyphenols and Atorvastatin
茶多酚和阿托伐他汀抑制肺癌发生
- 批准号:
8212578 - 财政年份:2008
- 资助金额:
$ 7.29万 - 项目类别:
相似国自然基金
髋关节撞击综合征过度运动及机械刺激动物模型建立与相关致病机制研究
- 批准号:82372496
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
探索在急性呼吸窘迫综合征动物模型和患者长时间俯卧位通气过程中动态滴定呼气末正压的意义
- 批准号:82270081
- 批准年份:2022
- 资助金额:76 万元
- 项目类别:面上项目
脆性X综合征动物模型中异常视觉信息处理和视觉注意力的神经环路机制研究
- 批准号:
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
无菌动物模型与单细胞拉曼技术结合的猴与人自闭症靶标菌筛选及其机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
雌激素抑制髓系白血病动物模型中粒细胞异常增生的机制
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
相似海外基金
Novel mechanisms of muscle and bone loss with HIV infection, antiretroviral therapy, and aging.
HIV 感染、抗逆转录病毒治疗和衰老导致肌肉和骨质流失的新机制。
- 批准号:
10696502 - 财政年份:2023
- 资助金额:
$ 7.29万 - 项目类别:
Developing Therapeutic Gel Embolic Agents for Arteriovenous Malformation Embolization
开发用于动静脉畸形栓塞治疗的凝胶栓塞剂
- 批准号:
10667726 - 财政年份:2023
- 资助金额:
$ 7.29万 - 项目类别:
The protective role of kidney-derived Tamm Horsfall protein (Uromodulin) in sepsis
肾源性 Tamm Horsfall 蛋白(尿调节蛋白)在脓毒症中的保护作用
- 批准号:
10886979 - 财政年份:2023
- 资助金额:
$ 7.29万 - 项目类别:
Deciphering the role of osteopontin in the aging eye and age-related macular degeneration
破译骨桥蛋白在眼睛老化和年龄相关性黄斑变性中的作用
- 批准号:
10679287 - 财政年份:2023
- 资助金额:
$ 7.29万 - 项目类别: